CXCR2 and neoplasm: Subsequently, secretion of CXCR2 ligands by inflamed tumor cells promotes the accumulation of CXCR2+ TANs, which in turn inhibits the cytotoxic activity of CD8+ T cells and facilitates tumor progression [87].